Skip to content

Hugo Registry

Hugo Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1042220132
Enrollment
450
Registered
2023-02-01
Start date
2023-07-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Robot Assisted Surgery

Interventions

None listed

Sponsors

Sekiguchi Yuta
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements - Patient has or is intended to receive or be treated with an eligible Medtronic product - Patient is consented within the enrollment window of the therapy received, as applicable

Exclusion criteria

Exclusion criteria: - Patient who is, or is expected to be, inaccessible for follow-up - Patient is currently enrolled or plans to enroll in concurrent drug/device study that may confound the PSR results

Design outcomes

Primary

MeasureTime frame
The complication rate related to the Hugo RAS system and/or procedure. (For benign gynecologic surgical procedures, surgical success rate is also included)

Secondary

MeasureTime frame
Additional information on the safety and performance of the Hugo RAS system (e.g. patient baseline characteristics, perioperative details, learning curve, robotic instruments used etc.)

Countries

Belgium, Chile, Denmark, France, Germany, Hongkong, India, Israel, Italy, Japan, Netherlands, Panama, Spain, Sweden, Switzerland

Contacts

Public ContactYuta Sekiguchi

Medtronic Japan

yuta.sekiguchi@medtronic.com+81-80-7208-8857

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026